Clinical Trial Update: Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE) [Phase 3]

View source ↗

Summary

The SPHERE Phase 3 pediatric trial investigating treatment for hypereosinophilic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypereosinophilic Syndrome

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypereosinophilic Syndrome | Phase 3 | Status: COMPLETED